Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma
Florence Magrangeas, Catherine Guérin‐Charbonnel, Victor Gaborit, Marie Denoulet, Nils Giordano, Aurore Perrot, Cyrille Touzeau, Mark van Duin, Magali Devic, Elise Douillard, Éric Letouzé, Pieter Sonneveld, Jill Corre, Stéphane Minvielle, Philippe Moreau
The paper analyzes transcriptomic subtypes in CASSIOPEIA patients to refine the prognostic value of MRD negativity in multiple myeloma, showing varying PFS rates across risk groups.
Blood Cancer Journal · Jul 2, 2026Peer-reviewedCancer Biology